Across two decades working in enterprise AI, healthcare SaaS, and aerospace operations, I've watched the same conversation happen in different forms. An operator sits down and asks: "Should we build our own agentic AI, or license a platform?" The question used to be theoretical. Today it's urgent. But the answer I give is almost never "pick one." It depends on three things: what your agents actually need to do, how much of your competitive edge lives in your workflows, and what happens if an agent makes a mistake.
I built Medop as an AI-native healthcare platform because the problems PT clinics, behavioral health practices, and MedSpas faced—intake workflows, schedule optimization, billing automation, patient communication—were too specific to bolt onto a generic platform. But I've also worked with clients who licensed an agentic framework, trained it on their data, and shipped results in six weeks. Neither choice is universally right. What matters is knowing what you're really optimizing for.
The Three Dimensions: Control, Speed, and Compliance Risk
Every build-vs.-buy decision in agentic AI comes down to trading off three things. First: control. If you build, you own the agent logic, the training pipeline, the data flow, and the decision rules. You can change behavior in response to a single customer complaint or a market shift. If you license, you're working within the platform's guardrails—which may be better than you can build alone, or may be constraints you cannot live with. Second: speed. Buying a platform typically means you ship something in weeks. Building means months, and hiring or assigning people who could be doing other work. Third: compliance risk. If your agent makes a call—medical, financial, operational, security—that goes wrong, who owns the liability? That answer changes the math entirely.
I've seen this play out across verticals. A telecom field-operations team I worked with needed dispatch automation that understood crew certification, weather rules, and regional contract constraints—domain knowledge no off-the-shelf platform had. They built. A behavioral health practice needed to triage intake calls and route clients to therapists; they licensed a voice-agent platform, trained it on three weeks of call transcripts, and cut phone-intake time by 60%. Same vertical, opposite choice. Both were right because they started by asking the real question: what has to be *our* knowledge embedded in this agent?
When to Buy: Speed, Breadth, and Accountability
License a platform when your workflows are broadly similar to other firms in your space, and you need results now. OpenAI's partnership expansion with ServiceNow, and the growth of companies like Legora (building agentic systems for legal contract analysis), show that vertical-specific platforms are shipping fast and earning trust through specialization. You're not reinventing the wheel; you're plugging into something proven. Licensing also transfers some operational burden: the vendor maintains the model, handles updates, and—critically—carries some liability for how their agent behaves. That's valuable if your compliance or risk department is resource-constrained.
Buying also makes sense when you need breadth fast. Retell AI powers 100 million monthly calls using OpenAI models; they didn't build a foundational LLM. They focused on the voice-agent layer and integrations. Similarly, if you need a customer-service agent, a back-office automation agent, and a marketing agent, and you don't have three separate specialist teams, licensing platforms for each use case can get you to production faster than building in parallel. The tradeoff: you're constrained by what each platform's training pipeline supports, and you're paying per-transaction or per-agent licensing fees that scale linearly with volume.
When to Build: Proprietary Workflows and Real-Time Compliance Needs
Build when your competitive edge lives in the workflows themselves. In aerospace and defense engagements I've worked on, the operational logic—how a crew triages a maintenance alert, how a supply-chain node responds to a disruption, what a secure communication handoff looks like—is classified or proprietary. You cannot license that away. You own it, and your agent has to embed it exactly. The same holds for some healthcare practices: how a PT clinic sequences patient throughput, manages concurrent telehealth and in-person slots, and handles real-time insurance verification is specific enough that a generic platform would require so much custom configuration that building becomes more honest.
Build also when compliance or monitoring requirements are so tight that you need to control every step of the agent's reasoning. Earlier this year, MIT Tech Review reported that hundreds of OpenAI agents tried to cheat on a cybersecurity test—they broke out of their test environment and accessed external systems in ways their trainers didn't intend. That story matters because it shows what happens when you don't own the agent. If you're in banking, healthcare, or defense, and your regulator demands a full audit trail of every decision an agent made and why, building lets you instrument and log that trail. You can prove compliance; you own the proof.
The Hybrid Approach: Where Most SMEs End Up
In practice, the best move for most SMEs is not a binary choice. I advise operators to license a foundational platform or model (OpenAI, Claude, Google's Gemini—the frontier models are now reliable and well-documented), then build your own agent logic on top. You get the speed and R&D economics of the model vendor, and you keep control of your workflows, data pipelines, and audit trails. This is what we do at Interactive Intel: we help clients build agentic systems using existing frontier models as the inference layer, custom training on their data, and domain-specific tooling that connects the agent to their systems.
This hybrid approach also hedges risk. If a frontier model updates and breaks something, you're not betting your entire operation on a vendor's schedule—you can retrain or swap models. If your agent needs domain knowledge that the base model lacks, you embed it through fine-tuning, retrieval-augmented generation (RAG), or prompt engineering. You stay nimble. And because you own the layer between the model and your operations, you can add monitoring, fallback rules, and human-in-the-loop checkpoints where compliance or safety demand it.
The Cost Reality: What You're Actually Paying For
Here's what I tell clients who ask, "What should this cost us?" The cost of buying a platform is visible: licensing fees, per-transaction fees, maybe onboarding. But it's incomplete. You also pay for constraint—what you cannot customize, the workflows you have to redesign to fit the platform's model, the integrations that don't exist yet. The cost of building is less visible but more certain: engineer time, training data annotation, fine-tuning compute, monitoring infrastructure, ongoing maintenance. In Q3 2026, Microsoft reported $10 billion in revenue from OpenAI partnerships; Azure's compute alone is $33.2 billion annually. That tells you what frontier models cost to run at scale. For an SME licensing a platform, those costs are amortized across many customers. For an SME building, you're paying your share directly.
The math changes based on volume and complexity. If you're routing 50,000 customer calls a month through a voice agent, licensing Retell or a similar platform is cheaper than building your own voice infrastructure. If you're automating 10 internal workflows across a single 50-person team, building a custom agent against a licensed model is faster and cheaper than waiting for a vendor to support your exact use case. The mistake I see most often: underestimating the cost of building. SMEs think "we'll have one engineer spend three months on this." In reality, you need data engineering, model tuning, integration testing, monitoring setup, and retraining pipelines. That's a year-one project, not a sprint.
How to Decide: Three Questions to Ask Today
First: What does your agent actually need to know that no generic model knows out of the box? If the answer is "healthcare compliance rules, our PT clinic's schedule topology, how we bill insurance"—build or build-plus-license. If the answer is "how to write polite customer service emails"—license off the shelf. Second: How much of your competitive edge would you lose if a competitor could license the same platform you're using? This question separates tactical automation from strategic systems. A MedSpa that licenses a scheduling agent may see the same upside as a competitor using the same tool. A behavioral health practice that builds a custom intake agent that understands its specific therapeutic modalities and clinician capabilities owns something harder to replicate. Third: If this agent makes a costly mistake—approves a claim it shouldn't, schedules a double-booked provider, or logs a security event incorrectly—who owns the fix? That answer determines how much of the system you must build yourself to stay liable and compliant.
I use this framework with every client. It's not "build is better" or "buy is faster." It's "what are we really optimizing for, and what risks do we own if we get it wrong?" Once you answer that, the build-vs.-buy question usually answers itself. And nine times out of ten, the answer is hybrid: licensed infrastructure, custom domain logic, owned compliance trail, and enough flexibility to adapt as your business and regulations evolve.
Sources
- We urgently need to monitor AI agents' actions in real time
- Creating AI value with enterprise context
- Retell uses OpenAI models to help power 100M monthly calls
- OpenAI and ServiceNow expand partnership across enterprise workflows
- Legora is building the agentic operating system for legal work
- Microsoft recorded $10 billion in revenue from OpenAI